Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10151
ProShares UltraPro Short 20+ Year Treasury
TTT
$27.5M
| $191K | ﹤0.01% |
+3,175
| New | +$203K |
2024 Q3
0 quarters
|
|
10152
TAT Technologies
TATT
$449M
| $191K | ﹤0.01% |
+10,460
| New | +$161K |
2024 Q3
0 quarters
|
|
|
SUPV
10153
CALL
Grupo Supervielle
SUPV
$622M
| $191K | ﹤0.01% |
26,800
+15,900
| +146% | +$110K |
2022 Q4
7 quarters
|
|
10154
CALL
Sana Biotechnology
SANA
$841M
| $191K | ﹤0.01% |
45,800
-55,000
| -55% | -$289K |
2022 Q2
9 quarters
|
|
10155
CALL
LifeMD
LFMD
$126M
| $190K | ﹤0.01% |
36,300
-23,200
| -39% | -$134K |
2021 Q1
14 quarters
|
|
10156
CALL
ProFrac Holding
ACDC
$856M
| $190K | ﹤0.01% |
28,000
+27,500
| +5,500% | +$193K |
2022 Q4
7 quarters
|
|
|
BBT
10157
Beacon Financial Corp
BBT
$2.27B
| $190K | ﹤0.01% |
7,058
-16,895
| -71% | -$442K |
2024 Q1
2 quarters
|
|
10158
PUT
POET Technologies
POET
$1.2B
| $190K | ﹤0.01% |
42,800
+28,500
| +199% | +$89K |
2024 Q2
1 quarter
|
|
|
KZR
10159
DELISTED
Kezar Life Sciences
KZR
| $190K | ﹤0.01% |
24,546
-23,773
| -49% | -$143K |
2019 Q1
22 quarters
|
|
10160
CALL
Kura Oncology
KURA
$939M
| $190K | ﹤0.01% |
9,700
-12,400
| -56% | -$251K |
2020 Q2
17 quarters
|
|
10161
Destination XL Group
DXLG
$21.9M
| $189K | ﹤0.01% |
+64,447
| New | +$201K |
2024 Q3
0 quarters
|
|
10162
Alto Ingredients
ALTO
$291M
| $189K | ﹤0.01% |
117,502
+62,356
| +113% | +$93.8K |
2019 Q4
19 quarters
|
|
10163
CALL
A10 Networks
ATEN
$2.14B
| $189K | ﹤0.01% |
13,100
-10,000
| -43% | -$135K |
2021 Q4
11 quarters
|
|
10164
CALL
Lakeland Financial Corp
LKFN
$1.41B
| $189K | ﹤0.01% |
2,900
+200
| +7% | +$13K |
2022 Q4
7 quarters
|
|
10165
YieldMax AI Option Income Strategy ETF
AIYY
$45.7M
| $189K | ﹤0.01% |
2,023
+941
| +87% | +$96.5K |
2024 Q2
1 quarter
|
|
10166
CALL
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$156M
| $188K | ﹤0.01% |
2,700
| – | – |
2017 Q2
29 quarters
|
|
10167
CALL
Metallus
MTUS
$827M
| $188K | ﹤0.01% |
12,700
+5,200
| +69% | +$93.5K |
2022 Q4
7 quarters
|
|
10168
Personalis
PSNL
$1.71B
| $188K | ﹤0.01% |
34,990
-320,251
| -90% | -$1.32M |
2019 Q2
21 quarters
|
|
10169
PUT
Liberty Global Class C
LBTYK
$2.9B
| $188K | ﹤0.01% |
8,700
-10,400
| -54% | -$205K |
2022 Q4
7 quarters
|
|
10170
CALL
GrafTech
EAF
$236M
| $188K | ﹤0.01% |
14,240
+2,700
| +23% | +$22.5K |
2018 Q3
24 quarters
|
|
10171
BV Financial
BVFL
$181M
| $188K | ﹤0.01% |
+12,239
| New | +$171K |
2024 Q3
0 quarters
|
|
10172
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.17B
| $188K | ﹤0.01% |
6,247
-9,571
| -61% | -$282K |
2024 Q1
2 quarters
|
|
|
AKTS
10173
DELISTED
Akoustis Technologies Inc
AKTS
| $188K | ﹤0.01% |
2,095,467
+2,061,467
| +6,063% | +$198K |
2020 Q4
15 quarters
|
|
10174
Direxion Daily Dow Jones Internet Bull 3X ETF
WEBL
$97.9M
| $188K | ﹤0.01% |
10,065
-3,503
| -26% | -$57.3K |
2022 Q3
8 quarters
|
|
|
PINE
10175
CALL
Alpine Income Property Trust
PINE
$323M
| $187K | ﹤0.01% |
10,300
+5,200
| +102% | +$90.6K |
2024 Q1
2 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.